Revenue segments as reported by the company.

Premiums

Services

Investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefits

Operating costs

Depreciation and amortization

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Humana

Humana Inc. engages in the provision of health insurance services. The firm operates through the following segments: Retail, Group and Specialty and Healthcare Services. The Retail segment consists of products sold on a retail basis to individuals including medical and supplemental plans such as Medicare, and State-based contracts. The Group and Specialty segment contains employer group fully-insured commercial medical products and specialty health insurance benefits marketed to individuals and groups, including dental, vision, military services and other supplemental health & voluntary insurance. The Healthcare Services segment offers services such as pharmacy solutions, provider services, clinical care, predictive modeling and informatics to other Humana businesses, as well as external health plan members, and other employers. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Humana exceeds earnings expectations, focuses on value-based care growth

Humana's strong financial performance and growth in value-based care position the company well for future success. Addressing audit error rates, uncertainties around RADV, and managing costs are key challenges. Opportunities in recruiting, revenue growth, and strategic partnerships offer avenues for further growth.

Humana exceeds Q1 expectations, eyes industry growth amidst challenges

Humana's strong Q1 performance and strategic decisions position it well for growth
Challenges like rate disruptions and Medicaid redeterminations require close monitoring
Opportunities in industry growth, member engagement, and benefit enhancements ahead
Commitment to long-term goals and high-quality service evident in company's outlook

Humana meets Q2 expectations, eyes growth in MA platform

Humana's Q2 performance met expectations with a focus on MA platform growth and disciplined investments.
Challenges include higher utilization in Medicare Advantage and broad-based medical cost trends.
Strategic benefits adjustments and competitive positioning present opportunities for growth and margin expansion.
Expectations for 2024 include maintaining market share, offsetting costs, and achieving strong membership growth.

Humana surpasses Q3 earnings expectations, eyes $37 EPS target

Humana's Q3 performance exceeded expectations, with strong membership growth and strategic initiatives driving future profitability.
While facing challenges in benefit ratios and regulatory changes, Humana remains focused on achieving long-term financial targets.
The company's commitment to operational excellence, membership growth, and pricing actions positions it for sustained success.
Strategic partnerships and risk management efforts showcase Humana's resilience and adaptability in a dynamic healthcare landscape.

Humana faces challenges from rising costs but eyes long-term growth

Humana's Q4 2023 earnings call highlighted challenges from increased medical costs and utilization trends impacting financial performance and outlook.
Despite disappointments in short-term results, the company remains confident in the long-term attractiveness of the Medicare Advantage sector.
Strategic efforts to restore margins, address utilization drivers, and engage with providers reflect a proactive approach to managing industry dynamics.
Balancing profitability with membership growth through benefit adjustments and pricing actions is crucial for Humana's sustainable financial performance.

Humana reports solid Q1 performance, eyes margin recovery in 2025

Humana's Q1 2024 earnings call highlighted a strong start to the year, challenges in the industry for 2025, and a focus on margin recovery and growth opportunities. The company remains confident in its outlook, emphasizing pricing discipline and maintaining a strong value proposition in the market.

Humana surpasses Q2 expectations, addresses cost pressures for growth

Humana's Q2 2024 performance exceeded expectations, driven by strong Medicare business and growth in Medicaid and primary care segments.
Challenges such as medical cost pressures were addressed through mitigation measures, while opportunities lie in strategic initiatives and long-term planning.
The company's focus on value, disciplined cost management, and operational efficiency position it well for sustained growth and value creation.

Humana surpasses Q3 expectations, eyes growth through efficiency and investments

Humana's Q3 performance exceeded expectations, with a focus on balancing earnings and investments. The company is strategically positioned to drive growth through membership expansion and operational efficiency. Challenges include managing costs and understanding market dynamics, with opportunities in improving Stars ratings and expanding senior care services.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Centene

On Friday, Centene Corp (NYSE:CNC) shares surged more than 4% in the morning after reports emerged suggesting American health insurance company Humana Inc. (NYSE:HUM) was planning an acquisition. StreetInsider pointed to speculative chatter that a Humana private jet was spotted near Centene's headquarters in St. Louis.

Should you buy CNC shares? Humana reportedly wants to buy Centene

Affirm

Ingersoll-Rand

Palo Alto Networks

Crown Castle International

CNO Financial Group

Genius Sports

Stocks were lower approaching midday on Friday, which looks to be duplicating a surprising Thursday, where all the indexes opened higher and reversed in the afternoon with all three closing in the red.

Friday Afternoon's Analyst Upgrades and Downgrades: Affirm, Ingersoll Rand, Palo Alto Networks and More

Humana (HUM) inks a deal with Curant Health to offer its members with chronic diseases enriched healthcare facilities.

Humana (HUM), Curant Health Team Up to Aid Chronic Patients

LOUISVILLE, Ky.--(BUSINESS WIRE)--Curant Health and Humana launch pilot program to address medication adherence and enhance patient care for members with complex health needs.

Curant Health and Humana Launch Pilot Program to Address Medication Adherence and Enhance Patient Care for Members with Complex Health Needs

Applied Materials

Activision Blizzard

Cintas Corp

Domino's Pizza

Expeditors International of Washington

Home Depot

Intercontinental Exchange

Intuit

KLA-Tencor

Lowe's

Lam Research

Mastercard

Moody's

MarketAxess Holdings

Monolithic Power Systems

Morgan Stanley

MSCI

Microsoft

NVIDIA

Roper Technologies

Charles Schwab

Sherwin-Williams

Thermo Fisher Scientific

T. Rowe Price Group

I present 30 High Growth Dividend Stocks for consideration in September 2021.

High Growth Dividend Stocks For September 2021

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Foundation donates $500,000 to support disaster recovery in the wake of Hurricane Ida.

Humana Foundation Donates $500,000 to Support Disaster Recovery in the Wake of Hurricane Ida

In trading on Wednesday, shares of Humana entered into oversold territory, hitting an RSI reading of 27.1

Humana Enters Oversold Territory

LOUISVILLE, Ky.--(BUSINESS WIRE)--The Humana Foundation donates $50,000 in relief efforts for those impacted by flooding in Tennessee.

Humana Foundation Donates $50,000 in Relief Efforts for Those Impacted by Flooding in Tennessee

COLLEGE STATION, Texas--(BUSINESS WIRE)--Texas A&M University Mays Business School and Humana to launch fifth annual Healthcare Analytics Case Competition.

Texas A&M University Mays Business School and Humana to Launch Fifth Annual Healthcare Analytics Case Competition

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that Bruce D. Broussard, President and Chief Executive Officer, will make a presentation to investors at the Morgan Stanley Conference on Wednesday, September 15, 2021, at 8:45 a.m. Eastern time. A live audio webcast of the presentation will be available via Humana's Investor Relations page at humana.com. The company suggests webcast participants sign on approximately 15 minutes in advance of the presentation to allow tim

Humana Inc. to Present at the Morgan Stanley 19th Annual Global Healthcare Conference

RingCentral

Twilio

Wall Street enthusiasm is muted yet the indices continually break records. Finding bargain stocks to buy is difficult but rewarding.

3 Stocks to Buy Into the Fall Season

Humana (HUM) reported earnings 30 days ago. What's next for the stock?

Why Is Humana (HUM) Down 6.5% Since Last Earnings Report?

Humana (HUM) closes its Kindred at Home buyout to bolster its home health and hospice business.

Humana (HUM) Acquires Remaining Shares at Kindred at Home

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today announced the successful completion of its acquisition of Kindred at Home (KAH), the nation's largest home health and hospice provider. With the addition of Kindred at Home, Humana is now the nation's largest provider of care in the home, significantly strengthening its ability to provide high-quality, whole-person healthcare that can improve patient health outcomes on a much broader scale. Humana is committed to delivering excelle

Humana Completes Acquisition of Kindred at Home

Humana share price has taken a downward spiral of late. Long-term prospects appear good, and there remains room for significant share price growth in the medium to longer term.

Humana: A Strong Buy The Dip

In trading on Thursday, shares of Humana entered into oversold territory, hitting an RSI reading of 29.1

Oversold Conditions For Humana

Bank of New York Mellon

Goldman Sachs

JPMorgan Chase & Co

Lockheed Martin

Northrop Grumman

Northern Trust

SS&C Technologies Hlds

Tractor Supply

Texas Instruments

UnitedHealth Group

Visa

ViacomCBS

I present 30 High Growth Dividend Stocks for consideration in August 2021. There are 4 new stocks on this month's watchlist, 3 with dividend yields above 2%.

High Growth Dividend Stocks For August 2021

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana highlights commitment to addressing health equity in 2020 corporate responsibility report

Humana Highlights Commitment to Addressing Health Equity in 2020 Corporate Responsibility Report

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (the “company”) (NYSE: HUM) announced today the completion of its public offering of $3.0 billion in senior notes. These senior notes are comprised of $1,500 million of the company's 0.650 percent senior notes, due 2023 (the “2023 notes”), at 99.933 percent of the principal amount, $750 million of the company's 1.350 percent senior notes, due 2027 (the “2027 notes”), at 99.905 percent of the principal amount and $750 million of the company's 2.150 p

Humana Completes Aggregate $3.0 Billion Debt Offering

LOUISVILLE, Ky.--(BUSINESS WIRE)--Leading health and well-being company Humana Inc. (NYSE: HUM) announced today that it is promoting health care industry veteran Sue Schick to President of the company's Group, Military and Specialty businesses, effective September 1, 2021. Schick came to Humana at the beginning of 2020 to join the segment's leadership team, with oversight of employer group sales and market operations. “From the day Sue arrived at Humana, the Management Team and I have been impr

Humana's Sue Schick Appointed President of Company's Group, Military and Specialty Businesses

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (the “company”) (NYSE: HUM) announced today that it has priced a public offering of $3.0 billion in senior notes. These senior notes are comprised of $1,500 million of the company's 0.650 percent senior notes, due 2023 (the “2023 notes”), at 99.933 percent of the principal amount, $750 million of the company's 1.350 percent senior notes, due 2027 (the “2027 notes”), at 99.905 percent of the principal amount and $750 million of the company's 2.150 pe

Humana Prices $3.0 Billion Debt Offering

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Ranks #1 for Customer Satisfaction for Mail Order for Four Consecutive Years in J.D. Power U.S. Pharmacy Study

Humana Ranks #1 for Customer Satisfaction for Mail Order for Four Consecutive Years in J.D. Power U.S. Pharmacy Study

Humana Inc. (HUM) CEO Bruce Broussard on Q2 2021 Results - Earnings Call Transcript

Humana's (HUM) second-quarter earnings gain from higher revenues and strong performances by its Retail and Healthcare Services segments.

Humana's (HUM) Q2 Earnings Surpass Estimates, Tumble Y/Y

Humana (HUM) delivered earnings and revenue surprises of 0.44% and 0.67%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

News for Humana Stock (HUM)